Nitrous oxide

Description

Nitrous Oxide USP is a non-flammable gas and oxidizer, classified under UN1070. It is available by prescription only and has a Chemical Abstracts Service (CAS) number of 10024-97-2.

Uses and Indications

This drug is indicated for use in medical settings where Nitrous Oxide is deemed appropriate for analgesia or sedation. Administration of Nitrous Oxide may be hazardous or contraindicated in certain situations. It is intended for use only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the requirement for a qualified healthcare professional to oversee its administration, ensuring patient safety and adherence to best practices. There are no specific teratogenic or nonteratogenic effects associated with this drug noted in the available data.

Dosage and Administration

Administration of Nitrous Oxide is to be conducted via the respiratory route through inhalation. The active ingredient is provided in a concentration of 990 mL per 1 L.

It is imperative that the administration of Nitrous Oxide is performed by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Healthcare professionals must adhere to the guidelines outlined in the Material Safety Data Sheet (MSDS) to ensure safe handling and administration practices.

Contraindications

Administration of Nitrous Oxide is contraindicated in the following situations:

• Use is restricted to licensed practitioners experienced in its administration, as improper use may pose significant hazards.

• Avoid breathing the gas directly, as it may lead to adverse respiratory effects.

• Contact with liquid Nitrous Oxide should be avoided to prevent injury to the eyes, skin, or clothing.

• The cylinder temperature must not exceed 52° C (125°F) to prevent potential hazards associated with overheating.

• The valve should be opened slowly to mitigate risks of rapid gas release.

• Ensure the valve is closed after each use and when the cylinder is empty to prevent accidental leakage.

• A back flow preventive device must be utilized in the piping to avoid contamination and ensure safe operation.

• Use must comply with the guidelines outlined in the Material Safety Data Sheet (MSDS) to ensure safety and efficacy.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazardous Properties Nitrous Oxide is classified as a high-pressure oxidizing liquid and gas. It vigorously accelerates combustion and can lead to rapid suffocation and anesthetic effects. Additionally, exposure may result in frostbite. Therefore, it is crucial to avoid inhalation of the gas and to ensure that it is stored and utilized in an environment with adequate ventilation.

Safety Precautions To mitigate risks, it is essential to keep oil and grease away from the gas. Equipment used must be specifically cleaned for oxygen and rated for cylinder pressure. Care should be taken to prevent liquid from contacting the eyes, skin, or clothing. The cylinder temperature must not exceed 52°C (125°F), and the valve should be opened slowly. After each use, and when the cylinder is empty, the valve should be securely closed. A backflow preventive device must always be employed in the piping system, and usage should adhere to the guidelines outlined in the Material Safety Data Sheet (MSDS).

First Aid Measures In the event of inhalation, the individual should be removed to fresh air immediately. If the person is not breathing, artificial respiration should be administered. If breathing difficulties arise, supplemental oxygen should be provided, and a physician should be contacted without delay. In cases of frostbite, immediate medical treatment is necessary.

Emergency Medical Assistance Healthcare professionals should be prepared to call for emergency medical help if Nitrous Oxide is inhaled or if frostbite occurs. No specific laboratory tests are required for the safe use of this agent, but vigilance in monitoring the patient's condition is essential.

Side Effects

Administration of Nitrous Oxide may pose significant hazards and is contraindicated in certain situations. It is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion. Patients may experience rapid suffocation due to its properties, and it can also induce anesthetic effects. Additionally, exposure to Nitrous Oxide may result in frostbite.

In the event of inhalation, it is crucial to remove the patient to fresh air immediately. If the patient is not breathing, artificial respiration should be administered. In cases where breathing is difficult, supplemental oxygen should be provided, and a physician should be contacted without delay. Should frostbite occur, obtaining medical treatment promptly is essential.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources as new data may emerge.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of Nitrous Oxide has not been specifically addressed in the available prescribing information. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for pediatric patients mentioned in the insert. Therefore, healthcare professionals should exercise caution and consider the lack of specific data when evaluating the use of Nitrous Oxide in children.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including considerations related to age, dosage adjustments, safety concerns, or any special precautions that should be taken for elderly patients. Healthcare providers should exercise caution when prescribing this medication to geriatric patients, as the absence of data necessitates careful monitoring and individualized assessment of treatment risks and benefits in this population.

Pregnancy

Administration of Nitrous Oxide may pose risks during pregnancy and is considered hazardous or contraindicated in this population. Healthcare professionals should exercise caution and ensure that Nitrous Oxide is used only by or under the supervision of a licensed practitioner experienced in its administration. Given the potential risks associated with its use in pregnant patients, careful consideration of the benefits and risks is essential before administration.

Lactation

There is no specific information available regarding the use of Nitrous Oxide in nursing mothers or its effects on lactation. Consequently, the potential excretion of Nitrous Oxide in breast milk and its impact on breastfed infants remain undetermined. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this agent.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses experience in its administration.

Hazards and Precautions

Nitrous Oxide is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion. This characteristic necessitates strict adherence to safety protocols to prevent accidents. The gas can lead to rapid suffocation and may induce anesthetic effects. Additionally, exposure to the gas can result in frostbite, particularly if the liquid form comes into contact with skin or mucous membranes.

To mitigate risks, it is crucial to avoid inhalation of the gas. Adequate ventilation must be ensured during storage and use. Furthermore, all oil and grease should be kept away from the gas, as these substances can pose additional hazards. Equipment utilized for Nitrous Oxide must be specifically cleaned for oxygen and rated for the cylinder pressure to ensure safety.

Operational Guidelines

The cylinder temperature must not exceed 52° C (125°F). When operating the cylinder, the valve should be opened slowly to prevent sudden release of gas. It is essential to close the valve after each use and when the cylinder is empty. A backflow preventive device should always be employed in the piping to avoid contamination and ensure safe operation. Users are advised to consult the Material Safety Data Sheet (MSDS) for comprehensive safety information.

First Aid Measures

In the event of inhalation, the affected individual should be removed to fresh air immediately. If the person is not breathing, artificial respiration should be administered. If breathing difficulties arise, supplemental oxygen should be provided, and a physician should be contacted without delay. In cases of frostbite, it is critical to seek medical treatment immediately to address potential tissue damage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No specific postmarketing experience details are available in the provided text. As such, there are no reported adverse events or case reports to summarize.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards or be contraindicated. It is essential that this substance is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must communicate the warning that Nitrous Oxide is a high-pressure oxidizing liquid and gas that vigorously accelerates combustion. Patients should be made aware that exposure can lead to rapid suffocation, anesthetic effects, and may cause frostbite.

Patients should be instructed to avoid breathing in the gas and to ensure that the area is adequately ventilated during use. It is crucial to keep oil and grease away from the equipment and to use only apparatus that has been cleaned for oxygen and is rated for cylinder pressure. Additionally, patients should be cautioned against allowing liquid Nitrous Oxide to come into contact with their eyes, skin, or clothing, and to ensure that the cylinder temperature does not exceed 52° C (125°F).

Healthcare providers should emphasize the importance of opening the valve slowly and closing it after each use and when the cylinder is empty. A backflow preventive device should always be utilized in the piping, and usage should comply with the Material Safety Data Sheet (MSDS).

In the event of inhalation, patients should be instructed to seek fresh air immediately. If breathing has ceased, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. It is imperative to call a physician for further assistance. In cases of frostbite, patients should obtain medical treatment without delay.

Storage and Handling

The product is supplied in a cylinder format, which must be handled with care to ensure safety and efficacy. It is essential to store and use the cylinder in an area with adequate ventilation to prevent the accumulation of potentially harmful gases.

To maintain the integrity of the product, it is crucial to keep oil and grease away from the cylinder and associated equipment. The equipment used must be thoroughly cleaned for oxygen service and rated for the appropriate cylinder pressure to ensure safe operation.

The temperature of the cylinder should not exceed 52° C (125° F) during storage and use. When operating the valve, it should be opened slowly to prevent sudden pressure changes. After each use, and when the cylinder is empty, the valve must be closed securely. Additionally, a backflow preventive device should always be utilized in the piping to safeguard against reverse flow.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Nordan Smith Welding Supply. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)